Members |
targetComponentId |
dikloxacillinnatrium 62,5 mg/5 ml, suspension |
Dicloxacillin 12.5 mg/mL oral suspension |
dikoboltedetatallergi |
Allergy to edetate (finding) |
didanosin 100 mg, pulver till oral lösning |
Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
didanosin 167 mg/förpackning, pulver |
Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
didanosin 250 mg/förpackning, pulver |
Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
didanosin 2 g/flaska, pulver |
Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
didanosin 4 g/flaska, pulver |
Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Dideoxyinosine |
Product containing didanosine (medicinal product) |
Dietary calorie intake |
Energy intake (observable entity) |
medelhögt intag av natrium via kosten |
Dietary sodium intake normal (finding) |
födoämnessubstans |
Edible substance (substance) |
Dietary treatment and advice |
Dietetic procedures (procedure) |
dietylpropionhydroklorid 75 mg, tablett med modifierad frisättning |
Product containing only amfepramone in oral dose form (medicinal product form) |
dietylpropionhydroklorid 75 mg, depåtablett |
Product containing only amfepramone in oral dose form (medicinal product form) |
Diethylpropion hydrochloride 75mg tablet |
Product containing only amfepramone in oral dose form (medicinal product form) |
svår intubation |
Difficult intubation |
talsvårigheter |
Difficulty talking |
diffust storcelligt B-cellslymfom, kategori |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
diffus unilateral subakut neuroretinit |
Diffuse unilateral subacute neuroretinitis |
difluprednat 0,05 %, emulsion för oftalmiskt bruk |
Difluprednate 500 microgram/mL eye suspension |
endoskop för matspjälkningssystemet |
Endoscope |
Digoxin 38mg/vial injection |
Digoxin immune fab only product |
Digoxin immune fab 38mg/vial powder for injection 4mL vial |
Digoxin immune fab only product |
digoxinspecifik antikropp 38 mg, pulver till injektionsvätska, flaska |
Digoxin immune fab only product |
antipsykotiskt medel innehållande dihydrokarbostyrilderivat |
Dihydrocarbostyril derivative |
dihydroergotaminmesylat 1 mg/ml, injektionsvätska, lösning, ampull |
Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dihydroergotaminmesylat 4 mg/ml, nässprej |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
dihydroergotaminmesilatallergi |
Allergy to dihydroergotamine |
Dihydrofolate reductase deficiency |
Deficiency of dihydrofolate reductase |
antipsykotiskt medel innehållande dihydroindolonderivat |
Dihydroindolone derivative (substance) |
Dilation of colon |
Dilation of colon |
Dilation of colostomy stoma |
Dilation of colostomy stoma |
dilitiazem 180 mg, tablett med modifierad frisättning |
Diltiazem only product in oral dose form |
diltiazem 180 mg, depåtablett |
Diltiazem only product in oral dose form |
dilitiazem 240 mg, tablett med modifierad frisättning |
Diltiazem only product in oral dose form |
diltiazem 240 mg, depåtablett |
Diltiazem only product in oral dose form |
dilitiazem 300 mg, tablett med modifierad frisättning |
Diltiazem only product in oral dose form |
diltiazem 300 mg, depåtablett |
Diltiazem only product in oral dose form |
dilitiazem 360 mg, tablett med modifierad frisättning |
Diltiazem only product in oral dose form |
diltiazem 360 mg, depåtablett |
Diltiazem only product in oral dose form |
dilitiazem 420 mg, tablett med modifierad frisättning |
Diltiazem only product in oral dose form |
diltiazem 420 mg, depåtablett |
Diltiazem only product in oral dose form |
diltiazemhydroklorid 420 mg, kapsel med modifierad frisättning |
Diltiazem only product in oral dose form |
diltiazemhydroklorid 420 mg, depåkapsel |
Diltiazem only product in oral dose form |
diltiazemhydroklorid, 5 mg/ml, lösning |
Product containing only diltiazem in parenteral dose form (medicinal product form) |
Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
gadopentetatdimeglumin 469,01 mg/ml, injektionsvätska, lösning, förfylld spruta |
Gadopentetic acid only product |
gadopentetatdimeglumin 469,01 mg/ml, injektionsvätska, lösning, flaska |
Gadopentetic acid only product |
Dingo dog breed |
Canis lupus dingo |
Dinoprostone 10mg insert |
Dinoprostone 10 mg prolonged-release vaginal pessary |
dinoproston 10 mg, vaginalinlägg |
Dinoprostone 10 mg prolonged-release vaginal pessary |
dinoproston 10 mg/ml, infusionskoncentrat, ampull 0,5 ml |
Dinoprostone 10 mg/mL solution for injection |
dinoproston 1 mg/ml, infusionskoncentrat, ampull 0,75 ml |
Dinoprostone 1 mg/mL solution for injection |
Dioxygenase |
Dioxygenase |
Dipeptide hydrolase |
Dipeptide hydrolase |
Dipeptidyl carboxypeptidase II |
Dipeptidyl carboxypeptidase II (substance) |
Dipeptidylpeptide hydrolase |
Dipeptidylpeptide hydrolase (substance) |
Dipetalonema perstans |
Mansonella perstans (organism) |
difenhydramid 2 % + zinkacetat 0,1 %, kräm för lokalt bruk |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
difenhydraminhydroklorid 12,5 mg/5 ml, elixir |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
difenhydraminhydroklorid 12,5 mg/5 ml, sirap |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
difenhydraminhydroklorid 6,25 mg/5 ml, sirap |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
Diphenhydramine hydrochloride 6.25mg/5mL syrup |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
extrakt specifikt för difenylmetandiisocyanat |
Diphenylmethane di-isocyanate |
Diphtheria and tetanus double vaccination NOS |
Administration of diphtheria and tetanus vaccine |
Diphtheria and tetanus double vaccination NOS |
Administration of diphtheria and tetanus vaccine |
hudtest för difteri |
Diphtheria toxin |
Diphtheria, pertussis and tetanus triple vaccination |
Administration of diphtheria, pertussis, and tetanus vaccine |
Diphtheria, pertussis and tetanus triple vaccination NOS |
Administration of diphtheria, pertussis, and tetanus vaccine |
Diphtheria, pertussis and tetanus triple vaccination NOS |
Administration of diphtheria, pertussis, and tetanus vaccine |
dipivefrinhydroklorid 0,1 %, ögondroppar |
Dipivefrine hydrochloride 1 mg/mL eye solution |
Dipivefrin hydrochloride 0.1% ophthalmic solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
Dipivefrin hydrochloride 0.1%wv solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
smutsig miljö |
Dirty environment (finding) |
DAS-schema (Disability assessment schedule) |
World Health Organization Disability Assessment Schedule 2.0 (assessment scale) |
utsöndring från suturlinje |
Discharge from suture line (finding) |
sjukdom orsakad av Fimbriariidae |
Disease caused by Fimbriidae (disorder) |
sjukdom orsakad av Thysanosomidae |
Disease caused by Thysanosomatinae (disorder) |
sjukdom orsakad av överfamiljen Syngamoidea |
Disease due to family Syngamidae |
Disease due to Cestoda |
Cestode infection |
Disease due to Orthopoxviridae |
Disease due to Orthopoxvirus |
Disease due to Parapoxviridae |
Disease due to Parapoxvirus |
Disease due to Reovirus |
Disease due to Orthoreovirus |
Disease due to Trematoda |
Trematode infection |
Disease of biliary tract |
Disorder of biliary tract |
Disease of endocrine gland |
Disorder of endocrine gonad |
Disease of supporting structures of teeth |
Periodontal disease |
Disease of teeth |
Tooth disorder |
Disease of thymus gland, NEC |
Disorder of thymus gland |
dinatriumedetatallergi |
Allergy to edetate (finding) |
biverkning av dinatriumetidronat |
Adverse reaction to etidronic acid |
dinatriumetidronatallergi |
Allergy to etidronic acid (finding) |
allergi mot dinatriumetidronat och kalciumkarbonat |
Allergy to etidronic acid (finding) |
biverkning av dinatriumpamidronat |
Adverse reaction to pamidronic acid (disorder) |
dinatriumpamidronatallergi |
Allergy to pamidronic acid (finding) |
Disodium tiludronate |
Product containing tiludronic acid (medicinal product) |
Disopyramide phosphate 100mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
disopyramidfosfat 100 mg, kapsel med modifierad frisättning |
Disopyramide only product in oral dose form |
disopyramidfosfat 100 mg, tablett med modifierad frisättning |
Disopyramide only product in oral dose form |
disopyramidfosfat 100 mg, depåkapsel |
Disopyramide only product in oral dose form |